CoChat

Clinical significance of antibodies against calcitonin

Grauer, A., Ziegler, R., Raue, F. · 2009 · Experimental and Clinical Endocrinology & Diabetes

The DOI matches its Crossref record.

Abstract

Calcitonin (CT) inhibits osteoclast-mediated bone resorption and is being used to treat Paget's disease of bone, hypercalcemia of malignancy and postmenopausal osteoporosis. The formation of antibodies against heterologuous calcitonins like salmon calcitonin (sCT) is common and occurs in 40-70% of the patients treated for more than 4 months. Not all of these patients, however, develop a secondary resistance to sCT, therefore the clinical significance of sCT antibodies is discussed controversially. In vivo and in vitro approaches demonstrate a neutralizing effect in 35 to 60% of the patient sera with antibodies against sCT. These neutralizing antibodies appear to explain most cases of clinically relevant secondary resistance to sCT treatment, which occurs in 25-45% of the patients after treatment periods of 6 months and longer. A positive treatment response to human CT after development of secondary resistance to sCT proves the diagnosis of antibody related resistance. Few cases develop secondary resistance in the absence of sCT binding antibodies, the mechanism of this phenomenon is unclear. Antibody related resistance is a significant problem in long term treatment with sCT. Especially in conditions like postmenopausal osteoporosis, where no readily accessable marker of treatment response is available, the development of sCT antibodies and their possible neutralizing effect has to be considered.

Overview

Integrity signals

Registry

Crossref · 10.1055/s-0029-1211376

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 38

Metadata

Authors
Grauer, A., Ziegler, R., & Raue, F.
Affiliations
Heidelberg University (DE)
Venue
Experimental and Clinical Endocrinology & Diabetes
Published
2009-07-15
Volume
103
Issue
06
Pages
345-351
ISSN
  • 0947-7349 (ISSN-L)
  • 1439-3646
OpenAlex
W1976679680
Cited by
38
References
0
Citations by year
2025: 1 · 2024: 3 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 2 · 2016: 1 · 2013: 2 · 2012: 2
FWCI
2.10
Type
journal article
Language
en
Open access
closed
Locations
  • Experimental and Clinical Endocrinology & Diabetes (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
Keywords
calcitonin, salmon calcitonin, neutralizing antibodies, postmenopausal osteoporosis, hypercalcemia of malignancy, Paget's disease of bone, human calcitonin, osteoclast resorption
MeSH terms
Animals, Antibodies, Calcitonin, Drug Resistance, Female, Humans, Hypercalcemia, Neoplasms, Osteitis Deformans, Osteoporosis, Postmenopausal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical significance of antibodies against calcitonin. https://app.cochat.ai/papers/10.1055/s-0029-1211376
The paper
Grauer, A., Ziegler, R., & Raue, F. (2009). Clinical significance of antibodies against calcitonin. Experimental and Clinical Endocrinology & Diabetes. https://doi.org/10.1055/s-0029-1211376

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.